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CD84 Leukocyte Antigen Is a New Member of the
Ig Superfamily
By Miguel Angel de la Fuente, Pilar Pizcueta, Marga Nadal, Jaime Bosch, and Pablo Engel
cDNA isolated from a human B-cell line Raji library was ana- (CD48 and HumLy9) have been mapped. CD84 monoclonal
lyzed and shown to encode the full-length cDNA sequence antibodies (MoAbs) were shown to react with cells trans-
of a novel cell-surface glycoprotein, initially termed HLy9-b. fected with the cloned cDNA. These MoAbs were further
The predicted mature 307-amino acid protein was composed used to show that CD84 is expressed as a single chain cell-
of two extracellular Ig-like domains, a hydrophobic trans- surface glycoprotein of Mr 64,000 to 82,000, which was
membrane region, and an 83-amino acid cytoplasmic do- highly glycosylated. CD84 had a unique pattern of expres-
main. The extracellular Ig-like domains presented structural sion, being found predominantly on lymphocytes and mono-
and sequence homology with a group of members of the Ig cytes. Thus, the glycoprotein HLy9-b is recognized by MoAbs
superfamily that included CD2, CD48, CD58, and Ly9. North- previously clustered as CD84 and represents a newly identi-
ern blot analysis showed that the expression of HLy9-b was fied member of the Ig superfamily that may play a significant
predominantly restricted to hematopoietic tissues. Chromo- role in leukocyte activation.
some localization studies mapped the HLy9-b gene to chro-
q 1997 by The American Society of Hematology.
mosome 1q24, where other members of this Ig superfamily
T Ly9, 2B4, and the recently described signaling receptorSLAM.9-11HE INTERACTION between leukocytes and other cellsregulate normal immune function. Along with the
polypeptides forming the T-cell and B-cell receptor com- CD84 is a cluster of differentiation that was established
during the Fifth International Leukocyte Differentiation An-plexes, a number of surface molecules participate in B-cell
and T-cell activation. Some function as cell-cell interaction tigen Workshop (Boston, MA, 1994). Three MoAbs, 2G7,
152-1D5, and 153-4D9, defined CD84 as a new surface anti-molecules or as signal-transducing elements, and some can
serve both functions.1 A significant number of these mole- gen predominantly expressed by mature B cells and mono-
cytes.12 More recently, biochemical analysis shows thatcules are members of the Ig superfamily, which are involved
in processes such as adhesion, migration, proliferation, dif- CD84 MoAbs precipitate a single-chain glycoprotein of ap-
proximately 72,000 to 86,000 Mr.13ferentiation, and effector functions of leukocytes.2
Extracellular portions of CD2, CD48, and CD58 leukocyte This article describes the molecular cloning, characteriza-
tion, chromosomal localization, and tissue-specific expres-antigens are predicted to have similar molecular structures,
and they form a distinct subgroup within the Ig superfamily, sion of a new gene of the Ig superfamily that encodes for
the cell surface leukocyte antigen CD84.named the CD2 family.3 These proteins have similar patterns
of conserved disulfide bonds and comprise N-terminal V-set
domains, which lack a disulfide bond, and C-terminal C2 set MATERIALS AND METHODS
Ig domains. These transmembrane surface glycoproteins are Isolation of cDNA clones. A cDNA library from the human
involved in adhesion interactions between T lymphocytes Burkitt lymphoma cell line Raji in lgt11 (Clontech Laboratories,
and accessory cells and generate intracellular activation sig- Palo Alto, CA) was used to isolate cDNA clones by cross-species
hybridization, with a mixture of different polymerase chain reactionnals.4-6 In vivo studies have shown that the administration
(PCR)-generated probes corresponding to sequences reported forof CD2 and CD48 monoclonal antibodies (MoAbs) can in-
murine surface molecule Ly99; the following primers were used tohibit T-cell responses and prolong allograft survival.7,8 Other
generate the probes: Ly9 #1 (559 bp): sense primer, 5*-AAGAAG-members of the growing CD2 family are the surface antigens
CTTCCAAGAATGAGTCAGCAGCAG-3*, and antisense primer,
5*-CATCGTATGTATTTAAATGGGTGTC-3*; Ly9 #2 (470 bp):
sense primer, 5*-GACACCCATTTAAATACATACGATG-3*, and
From the Fundacio´ ClıB nic per a la Recerca Biome`dica, the Uni- antisense primer, 5*-CAGTCTCTTGTAGACAAGCAAGG-3*; and
versity of Barcelona, Barcelona, Spain; the Departament de Gene`t- Ly9 #3 (445 bp): sense primer, 5*-CCTTGCTTGTCTACAAGA-
ica Molecular, the Institut de Recerca Oncolo`gica, Barcelona, GACTG-3*, and antisense primer, 5*-CAGAAAATTGTCCAT-
Spain; and the Hepatic Hemodynamic Laboratory, Liver Unit, Hos- GGCCAGTTG-3*.
pital ClıB nic of Barcelona, Barcelona, Spain. cDNA was obtained by reverse transcription polymerase chain
Submitted February 7, 1997; accepted May 19, 1997. reaction (RT-PCR) of total RNA isolated from murine thymus using
Supported by Grants No. PB-1562, SAF96-0120, and SAF97-0136 a First Strand cDNA Synthesis Kit for RT-PCR (Avian Myelo-
from the Comision Interminsterial de Ciencia y Technologia and blastosis Virus [AMV], Reverse Transcriptase; Boehringer Mann-
Grant No. PIRB-00076 of the Comissio´ Interdepartamental de Re- heim, Mannheim, Germany) and the Taq polymerase Expand High
cerca Tecnologia 1995. M.A.d.l.F. is a fellow of the Fondo Investi- Fidelity (Boehringer Mannheim) following manufacture’s instruc-
gaciones Sanitarias (97/5246). The GenBank accession number of tions. The PCR products were purified, subcloned into pSP64 vector
the cDNA clone is U82988. (Promega, Madison, WI), and random priming labeled using [g-32P]
dCTP with the Ready-To-Go DNA labeling kit (Pharmacia Biotech,Address reprint requests to Pablo Engel, MD, Fundacio´ ClıB nic,
Villarroel 170, Barcelona 08036, Spain. Uppsala, Sweden). Filter hybridization was performed in Ex-
pressHyb hybridization solution (Clontech Laboratories) at 457C forThe publication costs of this article were defrayed in part by page
charge payment. This article must therefore be hereby marked 2 hours, followed by low stringency washing in 21 SSC-0.05%
sodium dodecyl sulfate (SDS) at room temperature. Plaques that‘‘advertisement’’ in accordance with 18 U.S.C. section 1734 solely to
indicate this fact. were positive on duplicate filters were picked, and phage insert DNA
was isolated. cDNA inserts were removed by EcoRI digestion andq 1997 by The American Society of Hematology.
0006-4971/97/9006-0031$3.00/0 subcloned into pSP64 (Promega). Restriction maps were generated
2398 Blood, Vol 90, No 6 (September 15), 1997: pp 2398-2405
AID Blood 0021 / 5h3d$$$401 08-12-97 13:39:09 blda WBS: Blood
 For personal use only. at Harvard Libraries on August 27, 2013. bloodjournal.hematologylibrary.orgFrom 
CD84 LEUKOCYTE ANTIGEN 2399
and nucleotide sequences were determined by dideoxynucleotide Monocytes were isolated by adherence of blood mononuclear cells
to plastic for 60 minutes at 377C. Cell lines were cultured in completechain termination by using the T7 Sequencing Kit (Pharmacia Bio-
tech).14 A computer search of nucleotide and protein sequences was medium (RPMI 1640 supplemented with 10% fetal calf serum
[FCS], antibiotics, and 10 mmol/L glutamine). Cultures of all cellconducted using the Blast GeneSearch (National Center for Biotech-
nology Information, National Institutes of Health, Bethesda, MD). lines were split the day before analysis and were in logarithmic
growth.Sequence analysis was performed by using PC/Gene Software (Intel-
liGenetics Inc, Mountain View, CA). COS cells were transfected with the HLy9-b cDNA subcloned into
the pMT2 expression vector using the diethylaminoethyl-dextranRNA blot analysis. A positively charged nylon membrane, to
which poly A/ RNAs from 50 human tissue samples had been method.16 Cell surface expression was examined after 48 hours by
immunohistochemical analysis as described.17 Stable transfectantsimmobilized in separated dots (The Human RNA Master Blot), was
purchased from Clontech Laboratories. Poly A/ RNA samples on were produced by cotransfecting the murine pre–B-cell lines 300.19
by using 40 mg of pMT2-HLy9-b and 2 mg of pCI-neo vector con-Master Blot have been normalized to the mRNA expression levels
of eight different housekeeping genes allowing the determination of taining the neomycin resistance marker (Promega). The 300.19 cells
were transfected by electroporation (280 V, 950 mF) with a Genethe relative expression levels of a target mRNA in different tissues.
The nylon membrane includes poly A/ from the following tissues: Pulser II Apparatus (Bio Rad, Hercules, CA). After electroporation
the cells were plated in flat-bottomed 96-well tissue plates by lim-whole brain, amygdala, caudate nucleus, cerebellum, cerebral cortex,
frontal lobe, hippocampus, medulla oblongata, occipital lobe, puta- iting dilution, and selection of stable transfectants was performed
by using G418 (1 mg/mL; GIBCO/BRL).18 Twenty clones from themen, substantia nigra, temporal lobe, thalamus, subthalamic nucleus,
spinal cord, heart, aorta, skeletal muscle, colon, bladder, uterus, transfection were examined by indirect immunofluorescence screen-
ing, and the clone with the highest level of expression was used inprostate, stomach, testis, ovary, pancreas, pituitary gland, adrenal
gland, thyroid gland, salivary gland, mammary gland, kidney, liver, this study and maintained in the continuous presence of the selecting
drug.small intestine, spleen, thymus, peripheral leukocytes, lymph node,
bone marrow, appendix, lung, trachea, placenta, fetal brain, fetal MoAbs. The CD84 MoAbs 2G7 (IgG1), 152-1D5 (IgG1), and
153-4D9 (IgG1); and the MoAbs of the Unknown Panel were ob-heart, fetal kidney, fetal liver, fetal spleen, fetal thymus, and fetal
lung. Northern blot analysis was performed with nylon membranes tained from the Fifth International Workshop on Human Differentia-
tion Antigens, Boston MA, 1994.purchased from Clontech Laboratories (Multiple Tissue Northern
blot) to which 2 mg poly A/ RNA from different tissues (spleen, Immunofluorescence analysis. Cells were kept at 47C and exam-
ined immediately after isolation. Indirect immunofluorescence analy-lymph node, thymus, appendix, lung, and liver) have been blotted
after running on a denaturating formaldehyde/1.2% agarose gel. Dot sis of viable cells was performed after washing the cells twice. The
cells were then incubated for 20 minutes on ice with each MoAb asblot and Northern blot membranes were hybridized with a 1,040-bp
probe that contained the complete reading frame sequence of the ascites fluid diluted to the optimal concentration for immunostaining.
Isotype-matched murine MoAbs that were unreactive with humanHLy9-b clone and a 2,000-bp human b-actin cDNA as control probe.
Hybridization was performed according to the manufacturer’s in- leukocytes were used as negative controls. After washing, the cells
were treated for 20 minutes at 47C with FITC-conjugated goat anti-structions. Membranes were autoradiographed for 72 hours (HLy9-
b) or 4 hours (b-actin) at 0807C by using two intensifying screens. mouse Ig antibodies (Caltag, South San Francisco, CA). Single-
and double-color immunofluorescence analysis was performed onAutoradiography was scanned with a Bio-Profile densitometer
(Vilber Loumart, Marne la Vallee´, France) and the relative dot inten- an FACSCalibur (Becton Dickinson, Immnocytometry Systems, San
Jose, CA). At least 5,000 cells were analyzed for each sample.sity was determined with Bio-1D Analysis Software (Vilber Loum-
art). The relative dot intensity value was calculated as the optical Immunoprecipitation analysis. A total of 40 1 106 cells were
washed three times in phosphate buffered saline (PBS), resuspendeddensity (OD) of the dot minus the OD of the background.
Chromosomal mapping. Fluorescence in situ hybridization in 800 mL saline, and surface labeled with 200 mL of Biotin 1 mg/
mL (Sigma) for 20 minutes at 47C. After washing the cells once in(FISH), using a 1,040-bp cDNA probe that contained the complete
reading frame sequence of the HLy9-b and a 5.4-kb PCR-generated RPMI media with 10% FCS and four times in PBS, the cells were
lysed in 1 mL of buffer containing 0.5% (vol/vol) NP40 and proteaseprobe of genomic DNA of the HLy9-b gene (sense oligo: 5*-TCT-
GCTTGTTCTCATTCTGTCTTCA-3*; antisense oligo: 5*-CAG- inhibitors as described.19 Immunoprecipitations were carried out us-
ing 15 mg of the CD84 MoAbs 2G7 and 152-1D5. Cell lysates wereTAAGAGTTGGGCAGAGAAGAT-3*) were performed as pre-
viously described.15 Briefly, 2 mg of each probe was labeled with precleared three times for 2 hours using 50 mL (50% vol/vol) of
murine Ig-coated beads at 47C. Cell lysates were precleared againbiotin 16-dUTP (Boehringer Mannheim) by nick translation. A total
of 400 ng of labeled probe was precipitated along with 1 mg of Cot- overnight. The precleared lysate was then incubated with 50 mL of
CD84 MoAb-coated beads (50% vol/vol) or murine Ig-coated beads1 DNA (GIBCO/BRL, Gaithersberg, MD) and 1 mg of salmon sperm
(Sigma, St Louis, MO), and the pellet was resuspended in a hybrid- with constant rotation at 47C for 18 hours. Immunoprecipitates were
washed and analyzed by sodium dodecyl sulfate-polyacrylamide gelization mix. Ten microliters of the hybridization mix was applied to
each slide. After heat denaturation of the probe and the chromosomal electrophoresis (SDS-PAGE) as described.19 The samples were run
in the presence of 5% 2-mercaptoethanol (reducing conditions). Mrspreads, slides were incubated overnight at 377C. After the posthy-
bridization washes the slides were incubated with avidin-fluorescein was determined using prestained standard molecular weight markers
(GIBCO/BRL). The proteins were transferred by electroblotting withisothiocyanate (FITC; Vector Laboratories, Burigame, CA). Slides
were mounted with 40 mL of antifade solution (Vector Laboratories) glycine transfer buffer (96 mmol/L glycine, 12 mmol/L Tris-base in
10% methanol, pH 8.3) to polyvinylidene difluoride (PVDF) mem-containing 150 ng/mL of 4*,6*-diamidino-2-phenylindole. Slides
were studied under an Olympus AH-3 fluorescence microscope branes (Immobilon; Millipore, Boston, MA). After 2 hours of incu-
bation at room temperature with blocking solution (10% nonfat milk(Olympus Optical Co, Ltd, Tokyo, Japan) and images were analyzed
with the Cytovision System (Applied Imaging International LTD, in PBS), avidin peroxidase (100 ng/mL; Sigma) was added for 1
hour. The membranes were washed with PBS with 0.1% of Tween-Santa Clara, CA).
Cells. Blood was obtained by protocols approved by the Ethics 20, and the blot was developed using Amersham’s Enhancer Chemo-
luminiscence reagent (Amersham International, Little Chalfont, UK).Committee of the Hospital Clinic of Barcelona. Mononuclear cells
were isolated by Ficoll-Hypaque density gradient centrifugation. For N-deglycosysation, immunoprecipitates were digested overnight
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Fig 1. Nucleotide sequence and predicted amino acid sequence of HLy9-b. Potential N-linked glycosylation sites are underlined. Hydrophobic
stretches that would serve as a signal peptide region and a transmembrane region are double underlined. * indicates the termination codon.
at 377C with 0.4 U of Peptide-N-glycosidase F (PNGase F; Genzyme The 1,040-bp nucleotide sequence of clone HLy9-b #1 is
Diagnostics, Cambridge, MA) in buffer prepared according to the shown in Fig 1. The open reading frame encodes a 328-
manufacture’s instructions. amino acid protein, of which the first 21 amino acids com-
prise a typical hydrophobic signal peptide that is cleavedRESULTS
from the immature protein. The remaining 307-amino acid
Isolation and characterization of HLy9-b cDNA clones protein has a calculated molecular mass of 34,435 Mr before
and deduced amino acid sequence. Low stringency screen- the addition of sugars. There are four potential N-linked
ing of a human Burkitt lymphoma B-cell line Raji lgt11 glycosylation attachment sites in the mature protein consis-
library using murine Ly9 cDNAs as probes yielded several tent with the observed relative molecular weight on SDS-
positive clones. Four independent cDNA clones, named PAGE of 64,000 to 82,000 Mr. The sequence contains 11
HLy9-b #1 (2.4 kb), HLy9-b #2 (1.6 kb), HLy9-b #3 serine and 18 threonine residues, which could be O-glycosyl-
(1.3 kb), and HLy9-b #4 (1.4 kb), were isolated, and ated. There is a single 25-amino acid internal hydrophobic
they encoded a cDNA other than that described for HumLy9, segment that represents the transmembrane region and di-
the human homologue of murine Ly9 surface molecule.20 vides the protein in a 189-amino acid predicted external
After digestion of these clones with EcoRI two bands were segment and an 83-amino acid intracytoplasmic region.
observed. All these clones had an overlapping band of ap- Analysis of the sequence suggests that the extracellular por-
proximately 1,100 bp that showed a single open reading tion of HLy9-b is composed of two Ig-like domains. The
frame of 987 bp. The other EcoRI bands corresponded to NH2-terminal domain consisted of a V-like domain, which
lacks the usually conserved disulfide bonds between the bcDNA encoding 3* untranslated sequences.
AID Blood 0021 / 5h3d$$$401 08-12-97 13:39:09 blda WBS: Blood
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allowing us to determine the relative expression levels of
HLy9-b in different tissues and during development. HLy9-
b expression appeared to be lymphoid tissue specific: the
highest mRNA level was detected in lymph node, spleen,
and peripheral leukocytes (Fig 2A and B). Although at lower
levels, thymus and fetal spleen also expressed significant
levels of mRNA (Fig 2B), whereas it was very low in bone
marrow. Significant levels of mRNA for HLy9-b were de-
tected in kidney and, to a lesser extent, in lung (Fig 2A, C,
and data not shown). These two were the only nonlymphoid
tissues in which detectable levels of mRNA were observed.
Northern blot analysis from different lymphoid tissues and
lung showed a band of 4.4 kb (Fig 2C). No smaller RNA
species could be detected, even after a prolonged exposure
of the membranes, suggesting that the HLy9-b mRNA has
a long 3*-untranslated region.
HLy9-b is located at chromosome 1q24. To determine
the chromosomal localization of the HLy9-b gene FISH was
performed. By using the cDNA probe, pHLy9-b, a consistent
but not conclusive hybridization signal on chromosome 1
(band q24) was observed. To locate the gene more precisely,
the FISH method was performed using a 5.4-kb genomic
fragment of the HLy9-b gene, obtained by PCR. A total of
85% of the metaphases showed signal on 1q24, confirming
the localization obtained with the cDNA probe (Fig 3).
Identification of HLy9-b as CD84. To check whether
preexisting MoAbs were able to recognize the gene product
of HLy9-b cDNA, the Unknown Panel of MoAbs of the
Fifth International Workshop on Differentiation Antigen was
screened for MoAbs reactive with pMT2-HLy9-b–trans-
fected cells. Three MoAbs, 2G7, 152-1D5, and 153-4D9,
reacted with COS cells transfected with the HLy9-b cDNA,
but did not react with cells transfected with the expression
vector alone or with an unrelated cDNA (data not shown).Fig 2. mRNA analysis for HLy9-b. (A) Dot blot analysis of poly(A)"
These three MoAbs showed an identical and unique patternRNA from different tissues using labeled HLy9-b and b-actin cDNA
as probes. Autoradiography was scanned with a Bio-Profile densi- of expression and had been clustered as CDw84 during the
tometer (Vilber Loumart, Marne la Vallee´, France). (B) Quantification Fifth International Workshop.12 These MoAbs also specifi-
of mRNA in different lymphoid tissues. Dot relative intensity as mea-
cally stained a murine pre–B-cell line (300.19) stably trans-
sured with Bio-1D Analysis Software (Vilber Loumart). (C) Northern
fected with the 1,040 bp pHLy9-b cDNA (Fig 4). Expressionblot analysis of HLy9-b.
of CD84 on the transfected cells was determined on the basis
of anti-CD84 MoAb reactivity, measured by immunofluo-
rescence staining. The CD84 MoAbs did not react with un-sheets. The second domain had the structural features of an
transfected parent cells nor with cells transfected with vectorIg-truncated C2 set domain with two putative disulfide
alone. In all cases the reactivity pattern of the MoAb wasbonds. A protein sequence homology search showed that
identical. These results show that CD84 MoAbs identify thethis protein shared significant sequence identity with a group
protein encoded by the HLy9-b cDNA.of members of the Ig superfamily, including Ly9, CD48,
CD84 is highly glycosylated. The CD84 MoAbs wereCD58, and CD2. These data indicate that the HLy9-b gene
coupled to beads and used to immunoprecipitate the CD84encodes a protein that belongs to the Ig superfamily.
protein from detergent-solubilized extracts of biotinylatedThe predicted cytoplasmic domain of the mature protein
cell lines. Optimum results were obtained using the Raji cellcontains five tyrosines (Tyr). Interestingly, four of these Tyr
line because the level of CD84 expression was higher than(Tyr 241, Tyr 258, Tyr 278, and Tyr 303) contain motifs
in other cell lines (Fig 5). The CD84 antibodies specificallysimilar to those previously described as potential SH2 do-
immunoprecipitated proteins that migrated as a broad singlemain binding motifs. These are sequence motifs for kinase
band in the region from 64,000 to 82,000 Mr in SDS-molecules such as src-kinase type tyrosine kinases.21 There-
polyacrylamide gels (Fig 5).fore, sequences in the cytoplasmic tail suggest involvement
To determine the molecular mass of the protein in theof this molecule in signaling functions.
absence of N-linked sugars, surface-labeled CD84 proteinDetection of HLy9-b mRNA in hematopoietic tissues.
was digested with endoglycosydase F and analyzed by SDS-mRNA expression was examined by dot blot analysis using
poly A/ RNA isolated from 50 different human tissues, PAGE. After enzyme digestion, a loss of the 64,000 to
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Fig 3. Chromosomal localization of HLy9-b gene. Metaphase showing FISH with the HLy9-b 5.4-kb genomic probe. Double spots of hybridiza-
tion signal on chromosome 1 is indicated by an arrow. The HLy9-b gene was assigned to 1q24.
Fig 4. CD84 MoAbs reactive with the protein
product of the pHLy9-b cDNA. 300.19 cells trans-
fected with HLy9-b cDNA were examined by using
the CD84 MoAbs 2G7, 152-1D5, and 153-4D9 in indi-
rect immunofluorescence assays with flow cytome-
try analysis. Fluorescence histograms generated us-
ing 300.19 transfected cells are shown as solid lines.
Staining of the 300.19 untransfected cells are shown
as dotted lines. A MoAb against CD22 (HB22.7) was
unreactive with both transfected and untransfected
cell lines. Fluorescence intensity is shown on a three-
decade log scale.
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Fig 5. Immunoprecipitation of cell surface CD84
protein. Detergent lysates of surface-labeled Raji cell
line, 300.19 cells transfected with HLy9-b, and 300.19
untransfected cells were immunoprecipitated with
the 2G7 plus 152-1D5. The immunoprecipitated ma-
terials were treated with or without N-glycosidase
(PNGase F) and analyzed under reducing condi-
tions on a 10% SDS-polyacrylamide gel. Molecular
weights (kD) were determined by the migration of a
known protein standard.
82,000 Mr band and the appearance of a major component protein was similar in both cDNA-transfected cells (59,000
to 77,000; Fig 5) and Raji cells (64,000 to 82,000; Fig 5).at 45,000 and a fainter band of 36,000 Mr was observed
(Fig 5). Compatible with this observation CD84 has four Despite this difference in electrophoretic mobility between
the immunoprecipitates from the two cells, the bands ob-potential N-linked glycosylation sites (NXT/S) in the extra-
cellular domain. served after treatment with N-glycanase were the same for
both cell types (Fig 5). These results show that CD84 under-Immunoprecipitation with CD84 MoAbs of the 300.19
cell stably transfected with 1,040-bp pHLy9-b cDNA clone goes extensive post-translational processing as it was ex-
pressed as a single-chain molecule, yet the determined Mrshowed a broad band similar to the protein that was immuno-
precipitated from the Raji cells, except that the Mr was was more than twice the predicted size of the core protein.
In fact, differential use of these N-linked sites may explain57,000 to 77,000 (Fig 5). After treatment of the immuno-
precipitated material with endoglycosydase F, a dramatic the heterogeneity in size of the CD84 protein.
reduction in the molecular mass was also observed. A major Comparison of the CD84 amino acid sequences with other
band of 45,000 and a lighter one of 36,000 Mr identical to previously identified proteins showed a striking structural
those found in immunoprecipitates of the Raji cells line could homology with the extracellular Ig-like domains of a sub-
be detected. These results showed that the differences in group of the Ig superfamily surface receptors that includes
molecular mass between the protein in Raji cells and in the CD48, CD58, Ly9, and CD2, named the CD2 family. CD84
transfected cells were because of differences in the degree is most similar to murine and human Ly9, which are pre-
of glycosylation. dicted to encode a protein with four Ig-like domains in the
extracellular region.9,20 In contrast to Ly9, which has four Ig-
DISCUSSION like domains, CD84 like other members of the CD2 family is
composed of only two Ig-like domains. Comparison of Ig-In this study, we have isolated cDNA clones encoding for
like domains in human Ly9 (HumLy9) and CD84 showedthe leukocyte antigen CD84. The structural features of the
that the first domain of CD84 had 34.6% amino acid se-CD84 protein, predicted from nucleotide sequences derived
quence identity with domain 1 and 30.3% with domain 3 offrom the cDNA clone HLy9-b (Fig 1), showed that it en-
HumLy9; and the second domain of CD84 had 38.9% iden-codes a transmembrane type-I glycoprotein containing two
tity with domain 2 and 33.3% with domain 4.Ig-like domains in the extracellular region: a hydrophobic
Figure 6 shows sequence homology between CD84,membrane spanning domain, and an 83-amino acid cyto-
HumLy9, and human CD48. Although the sequences of theplasmic region (Fig 1). It is likely that the entire coding
domains share relatively little identity (25% to 39%), theregion of CD84 was identified as transfection of cell lines
core structures of the Ig-like domains are remarkably similar.with the pHLy9-b cDNA-generated cell-surface expression
of the protein (Fig 4) and the Mr of the immunoprecipitated Domain 1 of CD84 lacks a disulfide bond but is otherwise
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Fig 6. Ig-like domains of HLy9-b. HLy9-b Ig-like domains are compared with HumLy9 and human CD48. Solid lines above the sequence
predicted b-sheets. Conserved residues appear in stippled boxes. Gaps are indicated with broken line to allow optimal alignment of the
proteins. (A) First Ig-Like domain; (B) Second Ig-like domain. * indicates conserved amino acids of the Ig superfamily.
similar to V-like domains found in other proteins of the CD2 chromosome 1. Human CD2 and CD58 genes are located
on chromosome 1p13, whereas the CD48 and HumLy9 genesfamily.2,3 The second domain also shares homology with the
truncated C2 domain found in this group of members of the are situated on chromosome 1q21-24.20,22,23 These genes are
tightly linked with the ATP1A genes on chromosome 1,Ig superfamily. Four Cys residues, which are conserved in
all members of the CD2 family, were found in the putative which have evolved by gene duplication.24 By inference, it
is likely that duplication of a primordial gene also gave risesecond extracellular domain of CD84 (Fig 6). These Cys are
probably involved in the formation of two disulfide bonds. to the structurally related CD2, CD48, CD58, Ly9, and CD84
genes. It has been suggested that Ly9 and mouse CD48 shareOne pair of these residues at positions 134 and 172 delineates
an Ig-like domain creating the characteristic Ig-like loop a common ancestor that duplicated and diverged, to give rise
to a precursor of the Ly9 and CD48 genes, with a secondstructure and this domain contained many of the hallmark
amino acids that define the C2 set of Ig-like domains.2 duplication event producing the four-domain structure ob-
served in Ly9.9 The sequence similarities between CD84,The 83-amino acid cytoplasmic domain of CD84 con-
tained five tyrosine residues that could serve as potential Ly9, and CD48, together with the mapping of these genes
to the same chromosomal region, suggests that these threesites of phosphorylation. Four of these Tyr were contained in
two motifs Tyr-X-X-Leu/Ile and Tyr-X-X-Val with a general genes share a common ancestor.
CD84 expression appeared predominately to be lymphoid-sequence context that can serve as potential sites for SH2
domain recognition.21 These types of motifs have been tissue restricted as shown by Dot blot and Northern blot
analyses (Fig 2A, B, and C) and immunohistological analysisshown to be sites of interaction with multiple cytosolic pro-
teins, including tyrosine kinases, and are found in the cyto- of different tissues (data not shown). The highest levels of
CD84 mRNA were detected in lymph node, spleen, andplasmic domain of different signal transduction molecules,
indicating that CD84 may be involved in signal transduction. peripheral leukocytes (Fig 2A and B). These results are con-
sistent with the observation that CD84 is expressed by lym-The CD84 gene was mapped to chromosome 1q24 (Fig
3), where other members of this Ig superfamily (CD48 and phocytes and monocytes.13,25 Staining of lymph node and
spleen shows that CD84 is weakly expressed by lymphocytesHumLy9) have also been mapped. The genes of the members
of this family are located in two pericentric loci on human but strongly in scattered cells in the interfollicular zone,
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which is consistent with the observation that CD84 is not 376:260, 1995
present in pro-B or pre-B cells.25,26 In only 2 out of the 39 12. Tedder TF, Wagner N, Engel P: B-cell antigens section report,
nonlymphoid tissues analyzed, detectable levels of mRNA in Schlossman S (ed): Leucocyte Typing V. Oxford, UK, Oxford
were observed. Significant levels of mRNA for CD84 could University Press, 1995, p 483
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and monocytes. J Immunol 150:4719, 1993interactions and signal transduction.
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